Clinical trial reportMovement disorders : official journal of the Movement Disorder SocietyPublished
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease
Regional connection
Verified An author affiliation on the Europe PMC record names Cooper Medical School of Rowan University, with Rowan University linked by the institution reference. Affiliation source
- County
- Camden County
Publication record
- Type
- Clinical trial report
- Venue
- Movement disorders : official journal of the Movement Disorder Society
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Parkinson Disease; Indans; Antiparkinson Agents; Double-Blind Method; Benzothiazoles; Sleepiness; Pramipexole; Parkinson's Disease; Rasagiline; P2b001
- PubMed ID
- 37886872
- Added to directory
- Source checked